Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, ...

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Raining on the parade even more, Pfizer just reported some good news that seems to confirm the presence of some internal issues. So let's examine this new green flag that's also a red flag for anyone ...

On the 5th of November, the Latvian government approved the allocation of EUR 2.9 million from the budget of the Ministry of ...

Revelation: Pfizer’s Dangerous Knowledge About COVID-19 Vaccine Risks** New evidence is surfacing that suggests Pfizer was well aware of serious adverse events linked to its C ...

About Pfizer Stock Founded in 1849 and based out of New York City, Pfizer (PFE) is one of the foremost names when it comes to ...

Advertisement "This research provides valuable insights for policymakers and health communicators as they continue to ...

Driven by the early approval of its updated COVID-19 vaccine, BioNTech far exceeded analysts’ expectations in the third ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine ...

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...